ProCE Banner Activity

CCO Independent Conference Coverage: Clinical Impact of New Data From EASL 2021

Slideset Download
Conference Coverage
In this downloadable slideset, CCO’s expert faculty members summarize key viral hepatitis studies from this important conference, including new data on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.

Released: July 15, 2021

Expiration: July 14, 2022

Share

Faculty

Tarik Asselah

Tarik Asselah, MD, PhD

Professor of Medicine
Department of Hepatology
Hôpital Beaujon
Université de Paris-Cité & INSERM 
Clichy, France

Robert G. Gish

Robert G. Gish, MD

Medical Director
Complex GI and Specialty Services
California Pacific Medical Center
San Francisco, California

Nancy Reau

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Stefan Zeuzem

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Supporters

AbbVie

Antios Therapeutics

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Tarik Asselah, MD, PhD

Professor of Medicine
Department of Hepatology
Hôpital Beaujon
Université de Paris-Cité & INSERM 
Clichy, France

Robert G. Gish, MD

Medical Director
Complex GI and Specialty Services
California Pacific Medical Center
San Francisco, California

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany